Insider Trading Activity For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Eastern Capital Ltd , Major Shareholder of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reportedly Bought 850,000 shares of the company’s stock at an average price of 2 for a total transaction amount of $1,700,000.00 SEC Form
Insider Trading History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Analyst Ratings For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
These are 1 Buy Rating .
The current consensus rating for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) is Buy (Score: 3.00) with a consensus target price of N/A
Analyst Ratings History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
- On 8/12/2016 HC Wainwright Reiterated Rating Buy
Dividend History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Recent Trading Activity for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Shares of Cyclacel Pharmaceuticals, Inc. closed the previous trading session at 1.91 up +0.14 8.22% with 2,618,845 shares trading hands.